…enne (CE) marking),15 16 Deep Bio (prostate, breast and gastric cancer detection models with CE marking)17 and Ibex (breast and gastro…
PROState cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning PROState cancer
115 articles · page 7 of 10…ific life expectancy were evaluated from 40 to 90 years of age. Colorectal cancer, prostate cancer and bladder cancer yield much lower estimates …
…dose rate brachytherapy and ultra-fractionated radiotherapy for localised prostate cancer has demonstrated impressive survival statistics with low toxici…
…ong the androgen receptor targeted agents (ARTAs) used to treat prostate cancer, enzalutamide1 is a valid option at several stages of the disea…
…gues emphasise the urgent need to tackle ethnic inequalities in prostate cancer outcomes.1 If the UK National Screening Committee goes ahead wi…
…Müllerian duct cysts are rare congenital anomalies arising from persistent remnants …
…M, Bailey SER, et al. Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort …
…or multiple dispensations. It is intravenously administered for prostate cancer diagnosis using polypropylene, polyisoprene, or silicone syring…
…s (18%), prostate cancer (6%), chronic kidney disease (6%), and rheumatoid arthritis (5%), with other autoimmune diseases accounting for ~7%. About …
…e Apalutamide is an androgen receptor inhibitor, widely used in prostate cancer (PC). Hypothyroidism is a recognised adverse event; however, it…
…age was 78 years (standard deviation 5.65). Among them, 65% had prostate cancer, 10% gastric cancer, 10% breast cancer, and 5% had ovarian, ren…
…search to understand the factors driving ethnic inequalities in prostate cancer outcomes, say Habib Naqvi and colleagues…